BioMarin Pharmaceutical
BMRN
#1907
Rank
A$15.44 B
Marketcap
A$80.39
Share price
-0.78%
Change (1 day)
-21.62%
Change (1 year)

Market capitalization of BioMarin Pharmaceutical (BMRN)

Market cap: A$15.44 Billion

As of December 2025 BioMarin Pharmaceutical has a market cap of A$15.44 Billion. This makes BioMarin Pharmaceutical the world's 1907th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of BioMarin Pharmaceutical from 1999 to 2025

End of year Market Cap

Year Marketcap Change
2025A$15.44 B-24.64%
2024A$20.49 B-23.12%
2023A$26.65 B-5.68%
2022A$28.26 B26.33%
2021A$22.37 B8.08%
2020A$20.70 B-4.68%
2019A$21.71 B0.8%
2018A$21.54 B7.41%
2017A$20.05 B1.49%
2016A$19.76 B-14.91%
2015A$23.22 B41.04%
2014A$16.46 B45.55%
2013A$11.31 B89.96%
2012A$5.95 B55.53%
2011A$3.82 B30.57%
2010A$2.93 B38.74%
2009A$2.11 B-16.06%
2008A$2.51 B-35.95%
2007A$3.93 B106.19%
2006A$1.90 B74.22%
2005A$1.09 B105.53%
2004A$0.53 B-20.48%
2003A$0.66 B-0.48%
2002A$0.67 B-51.23%
2001A$1.38 B115.71%
2000A$0.63 B2.72%
1999A$0.62 B

End of Day market cap according to different sources

On Dec 5th, 2025 the market cap of BioMarin Pharmaceutical was reported to be:

A$15.44 Billion
by Nasdaq info icon info icon
A$15.44 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Ultragenyx Pharmaceutical
RARE
A$5.28 B-65.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
A$0.25 B-98.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
A$1.33 B-91.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$182.01 B 1,078.48%๐Ÿ‡ซ๐Ÿ‡ท France
Amicus Therapeutics
FOLD
A$4.59 B-70.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
A$4.35 B-71.81%๐Ÿ‡บ๐Ÿ‡ธ USA